Skip to main content
Erschienen in: Intensive Care Medicine 5/2016

29.01.2016 | Editorial

Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: we are not sure

verfasst von: Nitin Seam, Anthony F. Suffredini

Erschienen in: Intensive Care Medicine | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Excerpt

Many clinicians have ambivalence regarding the use of steroids in critical illness. In a survey of corticosteroid use in the ICU, more than half would use steroids in vasopressor-refractory septic shock while the majority of respondents almost never use corticosteroids for ARDS [1]. Considering the nature of the injury, the high mortality and the underlying pathogenesis of ARDS, this is somewhat surprising. Patients with ARDS with higher levels of lung and systemic inflammation have worse clinical outcome [2, 3]. Because of its inflammatory basis, corticosteroids have long been considered a potential therapy for ARDS. …
Literatur
1.
Zurück zum Zitat Lamontagne F, Quiroz Martinez H, Adhikari NK, Cook DJ, Koo KK, Lauzier F, Turgeon AF, Kho ME, Burns KE, Chant C, Fowler R, Douglas I, Poulin Y, Choong K, Ferguson ND, Meade MO (2013) Corticosteroid use in the intensive care unit: a survey of intensivists. Can J Anaesth 60:652–659CrossRefPubMed Lamontagne F, Quiroz Martinez H, Adhikari NK, Cook DJ, Koo KK, Lauzier F, Turgeon AF, Kho ME, Burns KE, Chant C, Fowler R, Douglas I, Poulin Y, Choong K, Ferguson ND, Meade MO (2013) Corticosteroid use in the intensive care unit: a survey of intensivists. Can J Anaesth 60:652–659CrossRefPubMed
2.
Zurück zum Zitat Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062–1073CrossRefPubMed Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062–1073CrossRefPubMed
3.
Zurück zum Zitat Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A (1995) Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108:1303–1314CrossRefPubMed Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A (1995) Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108:1303–1314CrossRefPubMed
4.
Zurück zum Zitat Meduri GU, Bridges L, Shih M-C, Marik PE, Siemieniuk RAC, Kocak M (2015) Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. doi:10.1007/s00134-015-4095-4 Meduri GU, Bridges L, Shih M-C, Marik PE, Siemieniuk RAC, Kocak M (2015) Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. doi:10.​1007/​s00134-015-4095-4
5.
Zurück zum Zitat Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533PubMed Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533PubMed
6.
Zurück zum Zitat Ruan SY, Lin HH, Huang CT, Kuo PH, Wu HD, Yu CJ (2014) Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 18:R63CrossRefPubMedPubMedCentral Ruan SY, Lin HH, Huang CT, Kuo PH, Wu HD, Yu CJ (2014) Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 18:R63CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Penuelas O, Cortes-Puch I, Cardinal-Fernandez P, Lorente JA, Frutos-Vivar F (2013) Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med 187:761–767CrossRefPubMed Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Penuelas O, Cortes-Puch I, Cardinal-Fernandez P, Lorente JA, Frutos-Vivar F (2013) Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med 187:761–767CrossRefPubMed
8.
Zurück zum Zitat Ewald H, Raatz H, Boscacci R, Furrer H, Bucher HC, Briel M (2015) Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev 4:CD006150PubMed Ewald H, Raatz H, Boscacci R, Furrer H, Bucher HC, Briel M (2015) Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev 4:CD006150PubMed
10.
Zurück zum Zitat Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, Lee HB, Lim CM, Koh Y, Korean Society of Critical Care Medicine HNC (2011) Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 183:1207–1214CrossRefPubMed Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, Lee HB, Lim CM, Koh Y, Korean Society of Critical Care Medicine HNC (2011) Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 183:1207–1214CrossRefPubMed
11.
Zurück zum Zitat Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L (2011) Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 183:1200–1206CrossRefPubMed Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L (2011) Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 183:1200–1206CrossRefPubMed
12.
Zurück zum Zitat Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errazuriz P, Martin-Pellicer A, Lorente JA, Frutos-Vivar F (2013) Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 1:395–401CrossRefPubMed Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errazuriz P, Martin-Pellicer A, Lorente JA, Frutos-Vivar F (2013) Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 1:395–401CrossRefPubMed
13.
Zurück zum Zitat Forel JM, Guervilly C, Hraiech S, Voillet F, Thomas G, Somma C, Secq V, Farnarier C, Payan MJ, Donati SY, Perrin G, Trousse D, Dizier S, Chiche L, Baumstarck K, Roch A, Papazian L (2015) Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med 41:1–11CrossRefPubMed Forel JM, Guervilly C, Hraiech S, Voillet F, Thomas G, Somma C, Secq V, Farnarier C, Payan MJ, Donati SY, Perrin G, Trousse D, Dizier S, Chiche L, Baumstarck K, Roch A, Papazian L (2015) Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med 41:1–11CrossRefPubMed
14.
Zurück zum Zitat Frohlich S, Murphy N, Boylan JF (2013) ARDS: progress unlikely with non-biological definition. Br J Anaesth 111:696–699CrossRefPubMed Frohlich S, Murphy N, Boylan JF (2013) ARDS: progress unlikely with non-biological definition. Br J Anaesth 111:696–699CrossRefPubMed
15.
Zurück zum Zitat Thompson BT, Moss M (2013) A new definition for the acute respiratory distress syndrome. Semin Respir Crit Care Med 34:441–447CrossRefPubMed Thompson BT, Moss M (2013) A new definition for the acute respiratory distress syndrome. Semin Respir Crit Care Med 34:441–447CrossRefPubMed
16.
Zurück zum Zitat Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280(2):159–165CrossRefPubMed Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280(2):159–165CrossRefPubMed
17.
Zurück zum Zitat Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M (2006) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684CrossRefPubMed Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M (2006) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684CrossRefPubMed
18.
Zurück zum Zitat Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131(4):954–963CrossRefPubMed Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131(4):954–963CrossRefPubMed
19.
Zurück zum Zitat Rezk N, Ibrahim A (2013) Effects of methylprednisolone in early ARDS. Egypt J Chest Dis Tuberc 62:167–172CrossRef Rezk N, Ibrahim A (2013) Effects of methylprednisolone in early ARDS. Egypt J Chest Dis Tuberc 62:167–172CrossRef
20.
Zurück zum Zitat Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della PR, Giorgio C, Blasi F, Umberger R, Meduri GU (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248CrossRefPubMed Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della PR, Giorgio C, Blasi F, Umberger R, Meduri GU (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248CrossRefPubMed
21.
Zurück zum Zitat Annane D, Sébille V, Bellissant E (2006) Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 34(1):22–30CrossRefPubMed Annane D, Sébille V, Bellissant E (2006) Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 34(1):22–30CrossRefPubMed
22.
Zurück zum Zitat Sabry NA, Omar EED (2011) Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm 2:73–81CrossRef Sabry NA, Omar EED (2011) Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm 2:73–81CrossRef
23.
Zurück zum Zitat Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, Qiu HB, Yang Y (2012) The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi 51(8):599–603PubMed Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, Qiu HB, Yang Y (2012) The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi 51(8):599–603PubMed
Metadaten
Titel
Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: we are not sure
verfasst von
Nitin Seam
Anthony F. Suffredini
Publikationsdatum
29.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 5/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-4160-z

Weitere Artikel der Ausgabe 5/2016

Intensive Care Medicine 5/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.